Recently Launched!
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Note: Free to use

Analysis of [OGN] Organon & Co.

Data updated 2025-May-05 (Monday)
 


Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab 
Youtube Thumbnail

Note: Detail for Organon & Co. as of 2025-May-05 Market Close includes Performance (day & prior periods), Technical Indicators and Benchmarks. Use Related Links to view other info such as Seasonality, Correlations, Financials and Recent news for [NYSE:OGN]

Share       
Other Dates:  
Time machine widget shows Historical Detail for Organon & Co. on other dates (from 2021-May-14)
2025-May-05 Monday
 Open $9.36   High $9.41 +0.53%
 Close $8.72   Low $8.63 -7.80%
Volume 14.5 Million 1.50x Volatility 9.04%
Change $-0.87 -9.07%
Streak ↓ 1 days -9.07%

 20d SMA $11.40 -23.5%  50d SMA $13.56 -35.7%  100d SMA $14.45 -39.7%  200d SMA $16.65 -47.6%
 RSI 29  MACD -0.16  ADX 33.8  Stochastic Oscillator 5.7 34.6
 CCI -198.6  ATR 0.87  OBV -214 Million  Chaikin A/D -105 Million
 
 Market Cap 4.67 B  PEG Ratio  Trailing P/E 4.58  Forward P/E
 Price/Sales (ttm) 0.75  Price/Book (mrq)  EV/Revenue (ttm) 2.03  EV/EBITDA (ttm) 8.87
 
 % Held by Insiders 0.14%  % Held by Institutions 79.93%  Shares Short 10.9 M  Shares Short (prior month) 9.71 M
 Short Ratio 5.27  Short % of Outstanding 4.28%  Short % of Float 4.29%  Shares Short Change (mom) +12.6%
 
 Revenue/Share (ttm) $24.54  Profit Margin (ttm) 16.33%  Operating Margin (ttm) 19.65%  EBITDA (ttm) 1.56 B
 Diluted EPS (ttm) $3.99  Current Ratio (mrq) 1.54  Return on Assets (ttm) 7.22%  Return on Equity (ttm)
 Qtr Earnings Growth (yoy) 405.60%  Qtr Revenue Growth (yoy) 7.60%  Operating Cash Flow (ttm) 799 M  Free Cash Flow (ttm) 395 M
 
Health Care Pharmaceuticals ADR:United States
Alerts: 52-week Low 200-day Volume

Anomalies  AI

Anomaly Detection for Organon & Co. looks at key performance metrics relative to it's history for Organon & Co. to identify unusual levels for 2025-May-05:

  • Intraday Swing at 9.0% is extremely high
  • 20-d Upswing at -34.3% is extremely low. Subsequent performance over next 10 days in such cases averages -0.5% and is down 100% of the time
  • 50-d Upswing at -46.1% is extremely low
  • 200-d Upswing at -62.3% is extremely low
  • 200-d Performance at -58.8% is extremely low
    • ...
    Sign Up or Login to see more performance anomalies

    Anomaly Detection for Organon & Co. looks at key technical metrics relative to it's history for Organon & Co. to identify unusual levels for 2025-May-05:

  • % off 100d EMA at -38.9% is extremely depressed. Subsequent performance over next 10 days in such cases averages -0.5% and is down 100% of the time
  • % off 20d SMA at -23.5% is extraordinarily depressed
  • % off 50d SMA at -35.7% is extremely depressed. Subsequent performance over next 10 days in such cases averages -0.5% and is down 100% of the time
  • CCI at -198.6 is extremely depressed
  • % off 50d EMA at -33.0% is extraordinarily depressed. Subsequent performance over next 10 days in such cases averages -0.5% and is down 100% of the time
    • ...
    Sign Up or Login to see more performance anomalies

     Anomaly Details
    Anomaly Detection uses Artificial Intelligence to find abnormal levels/metrics. Subsequent performance is aggregated for similar previous occurences in history and is called out if meaningful

    Choose view type

    Daily Performance for Organon & Co.. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)



    Note: Performance over Key Timeperiods for Organon & Co. up to close of 2025-May-05 at $8.72
    3-month Performance Benchmarks for Organon & Co.:


     Stock/Index/ETF:    vs.    vs.     vs.     vs.    
    Compare Performance for Organon & Co. with other stocks/etfs/crypto in a side-by-side presentation using this widget

    Related to Organon & Co.

    Information for Organon & Co.
      : Recent daily/monthly performance & benchmark comparison Currently Viewing
      : Historical performance & related information using Time Machine
      : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
      : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
      : Investigate unusual recent performance & technicals with historical context using AI
      : Seasonal performance by calendar months
      : History of Dividend Yield
      : Popular Technical indicator trends (RSI, MACD etc.)
      : Contextualizing recent performance & technical levels into historical decile buckets
      : Dollar Cost Average (DCA) over time in your portfolio
      : Key Simple & Exponential Moving Averages
      : Insights from closest historical matches to recent performance using Artificial Intelligence
      : Insights from similar historical charts to recent chart using Artificial Intelligence
      News Stories : News stories on 2025-May-05 on Google
      SEC Reports : Quarterly reports around 2025-May-05 on SEC Edgar

    Compare Organon & Co. with other assets
      : Recent performance across covered assets
      : Prior & Subsequent performance across assets on a historical date
      : Technical indicator levels across covered assets
      : Seasonal performance by calendar months across covered assets
      : Performance Correlations with other assets
      : Volatility relative to the broad market
      : Visually compare/benchmark performance with other assets over time
      : Contrast with other assets over time in a side-by-side presentation
      : Health Care sector performance which includes Organon & Co.
      : Pharmaceuticals industry performance which includes Organon & Co.
    Analyze Organon & Co. in multiple dimensions using above resources. Other comparable assets include other stocks/etfs/crypto etc.